Axa’s VIROPHARMA INC VPHM Stock Holding History

Axa’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-139,391	Closed	-$5.48M	–	1471
2013 Q3	$5.48M	Buy	139,391 +30,174	+28%	+$987K	0.03%	500
2013 Q2	$3.13M	Buy	+109,217	New	+$2.88M	0.02%	596

Other funds holding VPHM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Axa's VPHM Position: Q4 2013 in Review

Axa sold out of VIROPHARMA INC (VPHM) in Q4 2013, closing a stake of 139,391 shares — an estimated $5.48M sold.

Axa first reported a position in VPHM in Q2 2013 and held it in 2 quarters. The position peaked at $5.48M in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

Axa reported no remaining VIROPHARMA INC position as of Q4 2013 after selling out during the quarter.
Axa sold 139,391 VIROPHARMA INC shares in Q4 2013, an estimated $5.48M.
Axa first reported a position in VIROPHARMA INC in Q2 2013 and held it in 2 quarters.
Axa's VIROPHARMA INC position peaked at $5.48M in Q3 2013.
172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Axa's 13F filing for Q4 2013, filed 13 Feb 2014.